BioCentury
ARTICLE | Clinical News

[18F]-fluciclovine: Phase III started

April 11, 2016 7:00 AM UTC

Blue Earth began the open-label, U.K. Phase III FALCON trial to evaluate [18F]-fluciclovine in 180 patients who underwent radical curative treatment and have been diagnosed with biochemically recurren...